Fermented Protein for Pet Food Just Crossed the Production Threshold

Finnish biotech Enifer has completed a four-metric-ton production run of its PEKILO Pet mycoprotein ingredient, the first time the fermentation-derived protein has been available at volumes suitable for industrial formulation trials. Pet food manufacturers are now testing it across standard extrusion and retort lines. After years of alternative-protein pilot programs that never left the lab, this one is shipping to formulators.

What Happened

Enifer announced on April 2 that it completed its first industrial-scale production run of PEKILO Pet, a protein ingredient produced through a biomass fermentation process that converts agricultural and food industry by-products into a dry, powdered mycoprotein.

The numbers on the ingredient: 60% protein, 22% fiber, with smaller amounts of fat, minerals, and vitamins. It's delivered as a dry powder designed to integrate into both wet and dry pet food manufacturing systems, including extrusion and retort applications.

Enifer's full-capacity facility in Finland will produce 3,000 tons of PEKILO Pet annually when operating at scale. The company received a $13 million grant to construct the facility, and has separately partnered with FS in Brazil to expand PEKILO mycoprotein production in South America.

On the science side, a feeding trial published in peer-reviewed research found that PEKILO Pet matches the digestibility of premium animal-based diets in dogs while improving gut health markers. A separate study demonstrated superior carbon efficiency compared to soy protein, giving the ingredient a sustainability positioning alongside its nutritional profile.

Pet food manufacturers and brands are now running formulation trials under real production conditions, testing how the ingredient performs in their existing manufacturing processes.

Why It Matters

Alternative proteins have been circling pet food for years. Insect protein, hydrolyzed plant proteins, cultured meat, fermented biomass: the pitch decks pile up. What's been missing is commercial-scale supply that formulators can actually test in their existing production lines without retooling. This run changes that equation, at least for mycoprotein.

1. This solves the formulator's chicken-and-egg problem. Pet food manufacturers won't reformulate around an ingredient they can't source reliably. Ingredient companies can't justify production scale without committed buyers. A four-ton run at industrial spec is the bridge: enough volume for real formulation trials, enough data to give procurement teams a basis for supply agreements.

2. The protein and fiber profile fits a gap in the market. At 60% protein, PEKILO Pet competes with animal-derived protein meals on macronutrient density. The 22% fiber content is unusual and potentially valuable for the growing functional-nutrition segment, where gut health formulations are commanding premium shelf placement. For brands building around digestive wellness or weight management claims, high-protein-plus-high-fiber is a hard combination to achieve with conventional ingredients.

3. Sustainability claims are getting harder to make without receipts. "Sustainable" is table stakes in premium pet food marketing. But regulatory bodies and retailers are increasingly demanding lifecycle data, not just label claims. Enifer's published carbon-efficiency data against soy protein gives brands using PEKILO Pet a defensible sustainability story backed by third-party research, not just internal estimates.

4. The geographic diversification matters. Enifer's Finland facility plus its Brazil partnership with FS gives the company production capacity on two continents. For pet food manufacturers concerned about supply chain concentration (a lesson learned during pandemic-era ingredient shortages), multi-origin sourcing reduces risk.

What to Watch

Formulation trial results: The next milestone is whether pet food companies move from trial to commercial adoption. Watch for co-branded launches or ingredient callouts on packaging from recognizable pet food brands. If PEKILO Pet shows up in a product from a top-20 manufacturer, the ingredient category is validated.

Pricing relative to conventional proteins: The production economics at 3,000-ton annual capacity will determine whether mycoprotein competes with chicken meal and pea protein on cost, or whether it occupies a premium-only niche. Operators evaluating the ingredient need per-ton pricing relative to their current protein stack.

Regulatory pathway in the U.S.: Enifer is a European company with European regulatory clearances. U.S. pet food manufacturers will need clarity on AAFCO ingredient definitions and FDA compliance before PEKILO Pet can appear in domestically produced formulations at scale. Watch for AAFCO submissions or GRAS determinations.

The broader alternative protein race: Enifer's milestone will prompt comparisons with insect protein companies (Ynsect, InnovaFeed), cultured-meat startups (Bond Pet Foods, Because Animals), and other fermentation plays. The question isn't which technology wins; it's which ones can deliver at price points that make commercial formulation viable.

Source: Enifer announcement via Feed Business MEA